Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2019

01-08-2019 | IM - ORIGINAL

Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study

Authors: Maria Carmela Padula, Pietro Leccese, Emanuela Pellizzieri, Angela Anna Padula, Michele Gilio, Teresa Carbone, Nancy Lascaro, Giuseppina Tramontano, Giuseppe Martelli, Salvatore D’Angelo

Published in: Internal and Emergency Medicine | Issue 5/2019

Login to get access

Abstract

The Endoplasmic reticulum aminopeptidase protein 1 (ERAP1) trims N-terminal amino acids from epitope precursors for Major Histocompatibility Complex class I presentation. Genome-wide association studies demonstrated that ERAP1 gene single nucleotide polymorphisms (SNPs) are associated with Behçet’s syndrome (BS). This study was conducted on the two most consistently BS-associated ERAP1 polymorphisms, rs17482078 (NG_027839.1:g.35983G>A) and rs27044 (NG_027839.1:g.35997C>G) to analyse their distribution in 55 Italian BS patients and 65 ethnically matched controls (healthy controls, HC) and to test their association with BS risk. SNPs were detected by isolation, amplification of genomic DNA and direct sequencing. SNPs functional effects were predicted by bioinformatics software. The odds ratio (OR) with 95% confidence intervals was calculated to assess the strength of BS association for genotypes and alleles, also validated by logistic regression (LR). LR was used to test the association between both SNPs and patients HLA genetic data. Bonferroni correction was also applied. Comparing patients and controls, we found a significant higher frequency of rs17482078 A allele (32.73% BS vs 17.69% HC, p = 0.007) and AA genotype (18.18% BS vs 0% HC; p = 0.0003) and rs27044 G allele (63.64% BS vs 46.92% HC; p = 0.0096) in BS group after Bonferroni correction. No association was found between HLA-B*51 and both ERAP1 SNPs. Although preliminary, our data show a stronger association of rs17482078 with BS compared to rs27044 by means of case–control genetic analysis and bioinformatics prediction of protein structure change. A larger series of patients and controls is required to confirm our preliminary findings.
Literature
1.
go back to reference Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2016) One year in review 2016: Behçet’s syndrome. Clin Exp Rheumaol 34(Suppl 102):10–22 Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2016) One year in review 2016: Behçet’s syndrome. Clin Exp Rheumaol 34(Suppl 102):10–22
2.
go back to reference Leccese P, Yazici Y, Olivieri I (2017) Behcet’s syndrome in non endemic regions. Curr Opin Rheumatol 29(1):12–16CrossRefPubMed Leccese P, Yazici Y, Olivieri I (2017) Behcet’s syndrome in non endemic regions. Curr Opin Rheumatol 29(1):12–16CrossRefPubMed
4.
go back to reference Gul A (2015) Genetics of Behçet’s disease: lessons learned from genomewide association studies. Curr Opin Rheumatol 26:56–63CrossRef Gul A (2015) Genetics of Behçet’s disease: lessons learned from genomewide association studies. Curr Opin Rheumatol 26:56–63CrossRef
5.
go back to reference Sousa I, Shahram F, Francisco D, Davatchi F, Abdollahi BS, Ghaderibarmi F, Nadji A, Mojarad Shafiee N, Xavier JM, Oliveira SA (2015) Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 with Behçet’s disease in Iranians. Arthritis Rheumatol 67(10):2742–2748CrossRefPubMed Sousa I, Shahram F, Francisco D, Davatchi F, Abdollahi BS, Ghaderibarmi F, Nadji A, Mojarad Shafiee N, Xavier JM, Oliveira SA (2015) Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 with Behçet’s disease in Iranians. Arthritis Rheumatol 67(10):2742–2748CrossRefPubMed
6.
go back to reference Ohno S, Asanuma T, Sugiura S, Wakisaka A, Aizawa M, Itakura K (1978) HLA-Bw51 and Behçet’s disease. JAMA 240(6):529CrossRefPubMed Ohno S, Asanuma T, Sugiura S, Wakisaka A, Aizawa M, Itakura K (1978) HLA-Bw51 and Behçet’s disease. JAMA 240(6):529CrossRefPubMed
7.
go back to reference Xavier JM, Davatchi F, Abade O, Shahram F, Francisco V, Abdollahi BS, Trindade H, Nadji A, Shafiee NM, Ghaderibarmi F, Ligeiro D, Oliveira SA (2015) Characterization of the major histocompatibility complex locus association with Behçet’s disease in Iran. Arthritis Res Ther 17:81CrossRefPubMedPubMedCentral Xavier JM, Davatchi F, Abade O, Shahram F, Francisco V, Abdollahi BS, Trindade H, Nadji A, Shafiee NM, Ghaderibarmi F, Ligeiro D, Oliveira SA (2015) Characterization of the major histocompatibility complex locus association with Behçet’s disease in Iran. Arthritis Res Ther 17:81CrossRefPubMedPubMedCentral
8.
go back to reference Takeuchi M, Ombrello MJ, Kirino Y, Erer B, Tugal-Tutkun I, Seyahi E et al (2016) A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet’s disease in HLA-B*51 carriers. Ann Rheum Dis 75(12):2208–2211CrossRefPubMedPubMedCentral Takeuchi M, Ombrello MJ, Kirino Y, Erer B, Tugal-Tutkun I, Seyahi E et al (2016) A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet’s disease in HLA-B*51 carriers. Ann Rheum Dis 75(12):2208–2211CrossRefPubMedPubMedCentral
9.
go back to reference Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E et al (2013) Genome-wide association analysis identifies new susceptibility loci for Behçet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45(2):202–207CrossRefPubMedPubMedCentral Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E et al (2013) Genome-wide association analysis identifies new susceptibility loci for Behçet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet 45(2):202–207CrossRefPubMedPubMedCentral
10.
go back to reference Kang EH, Kim S, Park MY, Choi JY, Choi IA, Kim MJ, Ha YJ, Lee EY, Lee YJ, Lee EB, Kang C, Song YW (2017) Behçet’s disease risk association fine-mapped on the IL23R-IL12RB2 intergenic region in Koreans. Arthritis Res Ther 19(1):227CrossRefPubMedPubMedCentral Kang EH, Kim S, Park MY, Choi JY, Choi IA, Kim MJ, Ha YJ, Lee EY, Lee YJ, Lee EB, Kang C, Song YW (2017) Behçet’s disease risk association fine-mapped on the IL23R-IL12RB2 intergenic region in Koreans. Arthritis Res Ther 19(1):227CrossRefPubMedPubMedCentral
11.
go back to reference Reeves E, Edwards CJ, Elliott T, James E (2013) Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 191:35–43CrossRefPubMedPubMedCentral Reeves E, Edwards CJ, Elliott T, James E (2013) Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 191:35–43CrossRefPubMedPubMedCentral
12.
go back to reference Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, von Delft F, Kavanagha KL, Brown MA et al (2011) Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 108:7745–7750CrossRefPubMed Kochan G, Krojer T, Harvey D, Fischer R, Chen L, Vollmar M, von Delft F, Kavanagha KL, Brown MA et al (2011) Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci USA 108:7745–7750CrossRefPubMed
13.
go back to reference Ombrello MJ, Kastner DL, Remmers EF (2015) Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics. Curr Opin Rheumatol 27:349–356CrossRefPubMedPubMedCentral Ombrello MJ, Kastner DL, Remmers EF (2015) Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics. Curr Opin Rheumatol 27:349–356CrossRefPubMedPubMedCentral
14.
go back to reference Conde-Jaldon M, Montes-Cano MA, Garcia-Lozano JR, Ortiz-Fernandez L, Ortego-Centeno N, Gonzalez-Leon R et al (2014) Epistatic interaction of ERAP1 and HLA-B in Behçet disease: a replication study in the Spanish population. PLoS ONE 9:1–6CrossRef Conde-Jaldon M, Montes-Cano MA, Garcia-Lozano JR, Ortiz-Fernandez L, Ortego-Centeno N, Gonzalez-Leon R et al (2014) Epistatic interaction of ERAP1 and HLA-B in Behçet disease: a replication study in the Spanish population. PLoS ONE 9:1–6CrossRef
15.
go back to reference Weichsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N et al (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080 Weichsler B, Davatchi F, Mizushima Y, Hamza M, Dilsen N et al (1990) Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet 335(8697):1078–1080
16.
go back to reference Evans DM, Purcell S (2012) Power calculation in genetic studies. Cold Spring Harb Protoc 2012(6):664–674CrossRefPubMed Evans DM, Purcell S (2012) Power calculation in genetic studies. Cold Spring Harb Protoc 2012(6):664–674CrossRefPubMed
17.
go back to reference Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249CrossRefPubMedPubMedCentral Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249CrossRefPubMedPubMedCentral
18.
go back to reference Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT (2011) Basic statistical analysis in genetic case-control studies. Nat Protoc 6(2):121–133CrossRefPubMedPubMedCentral Clarke GM, Anderson CA, Pettersson FH, Cardon LR, Morris AP, Zondervan KT (2011) Basic statistical analysis in genetic case-control studies. Nat Protoc 6(2):121–133CrossRefPubMedPubMedCentral
19.
go back to reference Szumilas M (2010) Explaining Odds Ratios. J Can Acad Child Adoles Psychiarty 19(3):227–229 Szumilas M (2010) Explaining Odds Ratios. J Can Acad Child Adoles Psychiarty 19(3):227–229
20.
go back to reference Al-Okaily F, Arfin M, Al-Rashidi S, Al-Balawi M, Al-Asm A (2015) Inflammation-related cytokine gene polymorphisms in Behçet’s disease. Journal of Inflammation Research 8:173–180PubMedPubMedCentral Al-Okaily F, Arfin M, Al-Rashidi S, Al-Balawi M, Al-Asm A (2015) Inflammation-related cytokine gene polymorphisms in Behçet’s disease. Journal of Inflammation Research 8:173–180PubMedPubMedCentral
21.
go back to reference Core Team R (2016) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna Core Team R (2016) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
22.
go back to reference Wang X, Ma J, Ma J, Wen Y, Meng L, Yang H, Zhang R, Hao D (2017) Bioinformatics analysis of genetic variants of endoplasmic reticulum aminopeptidase 1 in ankylosing spondylitis. Mol Med Rep 16:6532–6543CrossRefPubMedPubMedCentral Wang X, Ma J, Ma J, Wen Y, Meng L, Yang H, Zhang R, Hao D (2017) Bioinformatics analysis of genetic variants of endoplasmic reticulum aminopeptidase 1 in ankylosing spondylitis. Mol Med Rep 16:6532–6543CrossRefPubMedPubMedCentral
Metadata
Title
Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet’s syndrome patients: a preliminary case–control study
Authors
Maria Carmela Padula
Pietro Leccese
Emanuela Pellizzieri
Angela Anna Padula
Michele Gilio
Teresa Carbone
Nancy Lascaro
Giuseppina Tramontano
Giuseppe Martelli
Salvatore D’Angelo
Publication date
01-08-2019
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 5/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02056-w

Other articles of this Issue 5/2019

Internal and Emergency Medicine 5/2019 Go to the issue

CE - Research Letter to the editor

Goebbels´ clubfoot: a case of osteomyelitis?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.